Document:

FORM OF NOTE 

 

THE ISSUANCE OF THIS PROMISSORY NOTE, AND
THE SECURITIES INTO WHICH IT IS CONVERTIBLE (COLLECTIVELY, THE “SECURITIES”), HAVE NOT BEEN REGISTERED WITH
THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THE SECURITIES ARE BEING OFFERED
PURSUANT TO CLAIMED EXEMPTIONS FROM REGISTRATION UNDER REGULATION D PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”). THE SECURITIES ARE “RESTRICTED SECURITIES” AND MAY NOT BE OFFERED OR RESOLD UNLESS
THE SECURITIES ARE REGISTERED UNDER THE ACT, OR ELIGIBLE TO BE OFFERED OR SOLD PURSUANT TO AN APPLICABLE EXEMPTION FROM SUCH REGISTRATION
REQUIREMENTS. THE COMPANY MAY REQUIRE THAT IT BE PROVIDED WITH OPINION OF COUNSEL OR OTHER SUCH INFORMATION AS IT MAY REASONABLY
REQUIRE TO CONFIRM THAT SUCH EXEMPTIONS ARE AVAILABLE. FURTHER, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE MADE EXCEPT
IN COMPLIANCE WITH THE ACT.

 

CRYOPORT, INC. 

 

US $____________

 

This Promissory Note (the “Note”)
is issued as of ______________ by Cryoport, Inc., a Nevada corporation (the “Company”),
to ___________ (together with its permitted successors and assigns, the “Holder”) with an address of
__________________ pursuant to exemptions from registration under the Securities Act of 1933, as amended.

 

ARTICLE I.

 

Section 1.01 Principal
and Interest. The Company hereby promises to pay on the Maturity Date specified in Section 1.02 the principal sum of US
$_________ and interest on such principal balance at the annual rate of five percent (5%).

 

Section 1.02 Maturity
Date. All unpaid principal and accrued interest hereunder shall be paid on June 30, 2014.

 

Section 1.03 Optional
Conversion to Preferred Stock. 

 

(a)Equity
Offering. The Company is currently in negotiations with prospective investors for the issuance by the Company of equity securities.
These securities may be common stock or preferred stock and may or may not involve the issuance of warrants to purchase equity
in the Company. The terms of such equity securities have yet to be established and there can be no assurance that such equity securities
will be issued. In the event, however, that the Company shall issue one or more types of equity securities (a “Transaction”)
before the maturity of this Note, the Company shall in each event notify the Holder in writing within ten (10) days of such issuance
of the terms of the Transaction and the Holder shall have the option until ten (10) days after such notice to convert all or a
portion of the principal and accrued interest under this Note into the equity securities that were issued by the Company at a per
share (or per unit) price that is equal to 90% of the per share (or per unit) price offered in such Transaction, but otherwise
on the same terms that the Company issued said securities in such Transaction. The Company shall not issue fractional shares upon
a conversion. If the application of the conversion price shall contemplate issuance of less than a half share, such fractional
share shall not be issued and no payment shall be made to the converting Holder and should such application result in the issuance
of a half or greater fractional share, such fractional share shall be rounded up to the next full share.

 

    	 

    	 

    

 

(b)Company
Discretion.

 

(i)At any time
after January 31, 2014, the Company may, but is not required to, offer the Holder the right to convert all or a portion of the
principal and accrued interest under this Note into units consisting of shares of common stock of the Company (“Common
Stock”) and a warrant to purchase additional shares of Common Stock. The number of shares of the Common Stock issued
upon conversion will be based on a conversion price that is equal to 70% of the average VWAP (as defined below) of the Common Stock
for the ten (10) consecutive trading days immediately prior to the date of such offer. For each share of Common Stock issued in
such conversion, the Holder will be issued the right to purchase, pursuant to a warrant, one share of Common Stock at an exercise
price equal to the 110% of such average VWAP. Such warrant will expire approximately five years from issuance and will otherwise
be in the same form as the warrant issued to the Holder in connection with the issuance of this Note. If the Company decides to
make such an offer, the Company shall in each event notify the Holder in writing and the Holder shall have the option until ten
(10) days after such notice to convert all or a portion of the principal and accrued interest under this Note into Units pursuant
to the terms of such notice. The Company shall not issue fractional shares upon a conversion. If the application of the conversion
price shall contemplate issuance of less than a half share, such fractional share shall not be issued and no payment shall be made
to the converting Holder and should such application result in the issuance of a half or greater fractional share, such fractional
share shall be rounded up to the next full share.

 

(ii)“VWAP”
means the volume-weighted average trading price of the Common Stock for the applicable period (which must be calculated utilizing
days in which the Common Stock actually trade); the VWAP shall be determined by dividing the aggregate sale price of all Common
Stock sold on the applicable exchange or market, as the case may be, over the applicable period by the total number of Common Stock
so sold.

 

(c)Restrictive
Legend. The certificates evidencing the Common Stock may bear the following or any similar legend (in addition to any other
legends that may be required):

 

“THESE SECURITIES HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR OFFERED
FOR SALE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES OR AN OPINION OF COUNSEL OR OTHER EVIDENCE ACCEPTABLE
TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

ARTICLE II.

 

Section 2.01 No
Prepayment. This Note may not be prepaid by the Company without the express written consent of the Holder.

 

Section 2.02 Pari
Passu With Other Notes. The payment of this Note and other similar notes issued for up to an aggregate principal sum of
$1,000,000 shall be made in full by the Company and if the Company is unable to fully repay all such notes, then payment shall
be on a pari passu basis.

 

ARTICLE III.

 

Section 3.01 Re-issuance
of Note. Should the Holder elect to convert a part, but not all, of the unpaid principal amount then owing to the Holder
under this Note, then the Company shall reissue a new Note in the same form as this Note to reflect the new principal amount and
the accrued and unpaid interest which was not converted.

 

Section 3.02 Notices.
Notices regarding this Note shall be sent to the parties at the following addresses, unless a party notifies the other parties,
in writing, of a change of address:

 

    	 

    	 

    

 

	If to the Holder, to:	 	 
	 	 	 

 

	If to the Company:	Cryoport, Inc.	 
	 	Attn: Chief Financial Officer	 
	 	20382 Barents Sea Circle	 
	 	Lake Forest, CA 92101	 

 

Section 3.03 Governing
Law. This Note shall be deemed to be made under and shall be construed in accordance with the laws of the state of Nevada
without giving effect to the principals of conflict of laws thereof.

 

Section 3.04 Severability.
The invalidity of any of the provisions of this Note shall not invalidate or otherwise affect any of the other provisions of
this Note, which shall remain in full force and effect.

 

Section 3.05 Entire
Agreement and Amendments. This Note represents the entire agreement between the parties hereto with respect to the subject
matter hereof and there are no representations, warranties or commitments, except as set forth herein. This Note may be amended
only by an instrument in writing executed by the parties hereto.

 

Section 3.06. No
Waiver, Cumulative Remedies. No failure to exercise and no delay in exercising, on the part any party, any right, remedy,
power or privilege hereunder, shall operate as a waiver thereof, nor shall any single or partial exercise of any right, remedy,
power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or
privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exhaustive of any rights, remedies,
powers and privileges provided by law.

 

Section 3.07 Waiver
of Trial by Jury. To the extent permitted by applicable Law, each of the parties irrevocably waives all right of trial
by jury in any action, proceeding or counterclaim arising out of or in connection with this Note or any matter arising hereunder.

 

Section .3.08 Legal
Holidays. In any case where the date on which any payment is due to any Holder shall not be a business day, then any such
payment need not be made on such date, but may be made on the next succeeding business day with the same force and effect as if
made on the date on which nominally due, and no interest shall accrue for the period from and after any such nominal date.

 

IN
WITNESS WHEREOF, with the intent to be legally bound hereby, the Company as executed this Note as of the date first written
above.

 

 

 

	 	CRYOPORT, INC.
	 	 	 
	 	By: 	___________________________________
	 	 	a duly authorized officerPLACEMENT AGENT AGREEMENT

(December 13, 2013)

 

This PLACEMENT AGENT
AGREEMENT is made by and between ANTRIABIO, INC., a Delaware corporation (the “Company”), and PAULSON
INVESTMENT COMPANY, INC., an Oregon corporation (“Placement Agent”), as of the date first above written.

 

WITNESSETH

 

WHEREAS, in reliance upon the representations,
warranties, terms and conditions hereinafter set forth, the Placement Agent will use its best efforts to: (i) privately place up
to $3,500,000 of the Company’s 8% unsecured convertible notes (each a “Convertible Note” and collectively,
the “Convertible Notes”) in a bridge financing (the “Bridge”); and (ii) privately place shares
of the Company’s common stock in a PIPE transaction (the “Financing”) as described in and pursuant to
the terms and conditions described in the term sheet attached hereto (the “Term Sheet”) as Exhibit A;

 

WHEREAS, the terms of the Financing
and the Bridge will be more fully described in the definitive documents to be prepared by Placement Agent and the Company with
the assistance of their respective counsel; and

 

WHEREAS, the Company desires to engage
the Placement Agent and the Placement Agent desires to be engaged as the Company’s placement agent in connection with the
Offering (as defined below).

 

NOW, THEREFORE, in consideration
of the premises and the respective promises hereinafter set forth, the Company and the Placement Agent hereby agree as follows:

 

1.     Services.

 

(a)     Placement Agent
shall offer participation in the Financing and the Bridge (collectively the “Offering”) to its clients and other
persons with whom Placement Agent or the Company or any of their respective officers, directors, employees or affiliates has a
pre-existing business relationship and which Placement Agent reasonably believes are “accredited investors” as defined
by Regulation D promulgated under the Securities Act of 1933, as amended (the “Securities Act”). Any such potential
investor in the Offering that is introduced to the Offering by Placement Agent shall be considered a qualified investor (collectively,
the “Qualified Investors”).

 

    	1

    	 

    

 

(b)     Placement Agent
shall be responsible for (i) the initial printing, binding and distribution (Placement Agent shall not be required to print hard
copies, but may use electronic documents for distribution) to the Qualified Investors of the Company’s confidential private
placement memorandum or other offering documents (the “Memorandum”) (which shall be created by the Company,
with the assistance of the Placement Agent, and shall include a brief summary of the Company and its business, current capitalization
table, current financial statements and certain future financial projections of the Company, as well as the relevant Financing
documents (the “Transaction Documents”)) and related investment materials to be used in connection with the
Financing, (ii) organizing, obtaining facilities for, and conducting one or more investor presentations and (iii) providing such
other services reasonably related to serving as placement agent for the Company in connection with the Financing. The Company shall
make members of management and other employees available to Placement Agent as Placement Agent shall reasonably request for purposes
of satisfying Placement Agent’s due diligence requirements and consummating the Financing, the Company shall also make key
management members available to attend a reasonable number of investor presentation, as determined by the Placement Agent, and
shall commit such time and other resources as are reasonably necessary or appropriate to secure the reasonable and timely success
of the Offering. The Company shall cooperate with Placement Agent in connection with, and shall make available to Placement Agent
such documents and other information as Placement Agent shall reasonably request in order to satisfy its due diligence requirements.

 

(c)     Placement Agent
acknowledges that (i) the Company may determine, in its sole discretion, whether to accept an offer of subscription to the
Financing or the Bridge by a Qualified Investor and (ii) the Company is not obligated to compensate Placement Agent for such
offered subscriptions to the Company that the Company does not accept. Notwithstanding the foregoing, unless the Company has a
specific objection to any particular Qualified Investor being an equity investor or creditor of the Company (for example, the investor
competes with the Company, is known to be disreputable or dishonest, is affiliated with a competitor of the Company or for other,
legitimate investor-specific reasons), the Company shall accept such offer of subscription from such Qualified Investors, as described
in the Term Sheet.

 

2.     Compensation.

 

(a)     Compensation
for the Bridge. The Company shall, at each closing of the Bridge, as compensation for the services provided by Placement
Agent hereunder pay Placement Agent a Bridge Cash Fee (as defined below). The Company will also pay a Bridge Conversion Fee (as
defined below) upon each conversion of all or part of the Bridge, whether such conversion was voluntary, or automatic.

 

(i)     The
“Bridge Cash Fee” shall equal 10.0% of the aggregate principal amount of each Convertible Note invested in by
Placement Agent and its affiliates and/or any Qualified Investor in the Bridge, including gross cash proceeds invested in the Bridge.

 

    	2

    	 

    

 

(ii)     The “Bridge
Conversion Fee” Upon the conversion of all or part of the Bridge, Placement Agent shall receive an additional cash fee
and warrant. The cash fee shall equal 5.0% of the outstanding principal and interest of the Bridge that is converted into the Company’s
equity securities. The Placement Agent shall also receive a warrant (the “Bridge Conversion Warrant”) to purchase
such number of shares of the Company’s common stock equal to 15% of the total outstanding principal amount of the Bridge,
that are converted into the Company’s equity securities. Each Bridge Conversion Warrant shall be exercisable for seven (7)
years with an exercise price of $0.26 per share, and shall have standard terms, cashless exercise rights, and shall be adjusted
both as to the number of shares and price into which and at which they are exercisable, based on any splits, conversions, or reorganizations
that affect the Company’s common stock. Additionally, in the event that the Company reduces the strike or exercise price
of any of its outstanding options or warrants, it will reduce the exercise price of the Bridge Conversion Warrants by the same
percentage. In the event that the Company offers its securities at a valuation lower than the pre-money valuation of the Financing,
the Company agrees to reduce the exercise price of the Bridge Conversion Warrants to a price per share equal to the effective price
per share of such financing.

 

(b)     Compensation
for Financing. The Company shall, at each closing of the Financing, as compensation for the services provided by Placement
Agent hereunder (i) pay Placement Agent a Cash Fee (as defined below) and (ii) issue a warrant (the “Financing Warrant”).

 

(i)     The Cash
Fee shall equal 10% of the gross cash proceeds invested by Placement Agent and its affiliates and/or any Qualified Investor
in the Bridge, including gross cash proceeds invested in the Financing.

 

(ii)      At each closing of the Financing,
the Company shall issue a Financing Warrant to purchase such number of shares of the Company’s common stock equal
to 15% of gross proceeds of the Financing. Each Financing Warrant shall have an exercise price of $0.26 per share, and shall be
exercisable for a term of seven (7) years from the date of issuance and shall have standard terms, cashless exercise rights, and
shall be adjusted both as to the number of shares and price into which and at which they are exercisable, based on any splits,
conversions, or reorganizations that affect the Company’s common stock. Additionally, in the event that the Company reduces
the strike or exercise price of any of its outstanding options or warrants, it will reduce the exercise price of the Financing
Warrants by the same percentage. In the event that the Company offers its securities at a valuation lower than the pre-money valuation
of the Financing, the Company agrees to reduce the exercise price of the Financing Warrants to a price per share equal to the effective
price per share of such financing.

 

(c)     Registration
Rights. The Company has agreed to use its commercially reasonable efforts to file a registration statement under the Securities
Act within thirty (30) days following the final closing of the Financing. The Company shall register the shares exercisable pursuant
to the Bridge Conversion Warrants and the Financing Warrants on such registration statement.

 

    	3

    	 

    

 

3.     Term. Placement Agent
shall serve as the Company’s exclusive placement agent for a period of eighteen (18) months from the date set forth above
unless earlier terminated as set forth herein (the “Term”).

 

4.     Termination.
Prior to the end of the Term, the Company may terminate this Agreement immediately and without notice in the event of a material
breach of this Agreement by Placement Agent. In the event the Company terminates this Agreement, Placement Agent will be
entitled to all applicable fees set forth in Section 2 hereof, earned prior to such termination. Upon termination of this
Agreement, Placement Agent shall prepare and deliver to the Company a definitive list of prospective Qualified Investors contacted
by Placement Agent in connection with the Offering with whom the Company had discussions by meeting or telephone conference during
the Term of this Agreement (the “Listed Investors”). If the Financing does not close, in the event that the
Company consummates a sale of any of its debt securities, equity securities or securities convertible into or exercisable in exchange
for equity securities to any Listed Investor, or any debt securities held by Listed Investors are converted to equity securities
within a period of eighteen (18) months following the date of termination of this Agreement (the “Tail Period”),
then at each closing thereof, the Company shall pay all fees to Placement Agent, including the issuance of warrants as set forth
in Section 2  hereof, in amounts equal to what Placement Agent would have earned from such sales had the Company closed
on such investments under the terms of this Agreement.

 

5.     Performance.
In connection with the performance of its duties under this Agreement, Placement Agent agrees as follows:

 

(a)     Placement Agent
shall act in a manner consistent with the instructions of the Company and comply with all applicable laws, whether foreign or domestic,
of each jurisdiction in which Placement Agent proposes to carry on the business contemplated by this Agreement. Placement Agent
shall not take any action or omit to take any action that would cause the Company to violate any law or any applicable exemption
from registration under the Securities Act or the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
Placement Agent is a member firm of the Financial Regulatory Authority (“FINRA”), has all authority and approvals
needed to engage in securities trading and brokerage activities, as well as providing investment banking and financial advisory
services. Placement Agent shall keep a record of when and to whom each Memorandum is provided. Placement Agent may elect to comply
at its’ discretion with this Section 5(a) by posting the Memorandum in a password protected data room, and maintaining
a file of that confirms who has viewed the Memorandum, and at what times on which dates.

 

    	4

    	 

    

 

(b)     Placement Agent
shall provide information regarding the Company only that is contained in the Company’s public filings, or which is, approved
in form and content by the Company for dissemination to potential investors (such as a PowerPoint presentation) or other information
that is available generally to the public (such as press releases or published articles) and shall not make any additional statements
that contain an untrue statement of a material fact or omit to state any fact necessary to make any statement made by Placement
Agent made not misleading in light of the circumstances in which they were made.

 

(c)     Placement Agent
shall not provide the Memorandum or any other information about the Company to any person or firm that, to the knowledge of Placement
Agent, is a competitor of the Company or is an officer, director, employee, affiliate or significant investor in the Company.

 

(d)     Placement Agent
shall not engage in any form of general solicitation or general advertising with respect to the Financing.

 

(e)     Before mentioning
or sending any material related to the Company to any potential investor, Placement Agent shall, on the basis of Placement Agent’s
prior relationship with the potential offeree, reasonably believe that the potential offeree is: (x) an “accredited
investor” and, if applicable, satisfies any private placement requirements or laws or regulations associated with the Financing
applicable in any non-U.S. jurisdiction and (y) so sophisticated and knowledgeable in business and financial matters that
the potential offeree is capable of evaluating the merits and risks of an investment in the Company. In furtherance thereof, Placement
Agent shall obtain from each Qualified Investor an accredited investor questionnaire in substantially the form attached hereto
as Exhibit C.

 

(f)     Placement Agent
shall use its best efforts to cause its officers, directors, employees and affiliates to comply with all of the foregoing provisions
of this Section 5.

 

    	5

    	 

    

 

6.     Representations
and Warranties.

 

(a)     Placement Agent
represents and warrants that it has full legal right to enter into and perform this Agreement and that its entry into and performance
under this Agreement do not and will not violate any fiduciary or other duty it may have to any other person. Placement Agent represents
and warrants that Placement Agent has and will maintain during this Agreement all licenses, registrations, permits and other authorizations
required for Placement Agent to perform the activities and receive the compensation contemplated by this Agreement in each jurisdiction
in which Placement Agent proposes to engage in such activities. In particular, but without limiting the generality of the foregoing,
Placement Agent is and will be duly licensed or registered as a broker dealer or registered representative of a broker dealer under
the Exchange Act, and under the laws of each jurisdiction requiring such licensing or registration. This Agreement, when executed
and delivered by the parties hereto, shall constitute a valid and binding obligation of Placement Agent, enforceable in accordance
with its terms, subject to laws of general application relating to bankruptcy, insolvency, the relief of debtors and federal and
state securities laws.

 

(b)     Placement Agent represents and warrants
that it shall at all times provide its services under this Agreement in compliance with applicable law, including but not limited
to, conducting an offering of a possible financing in a manner intended to qualify it as exempt from the registration requirements
of the Securities Act, except for an initial public offering, not taking any action in connection with an offering of a possible
financing which would constitute a general solicitation or general advertising, and not making any offers to any potential investor
which it does not reasonably believe to be an “accredited investor” within the meaning of Rule 501(a)(1), (2), (3)
or (7) under Regulation D of the Securities Act.

 

(c)     Placement Agent
is a member in good standing of FINRA, and is registered as a broker/dealer under the Securities Exchange Act of 1934, as amended.

 

(d)     The Company has the full right, power
and authority to execute, deliver and perform under this Agreement. This Agreement has been duly executed by the Company and this
Agreement and the transactions contemplated by this Agreement, have been duly authorized by all necessary corporate action and
this Agreement constitutes, and, upon their execution and delivery, the Bridge Conversion Warrant and the Financing Warrant will,
each constitute, the legal, valid and binding obligations of the Company, enforceable in accordance with their respective terms.

 

(e)     The
Company represents and warrants that the Memorandum and any other materials provided by the Company to the Placement Agent for
dissemination to potential investors contain no misrepresentation of a material fact, and do not omit a material fact necessary
to make the statements therein not misleading in light of the circumstances under which they were made, except that with respect
to assumptions, projections, forward-looking statements and expressions of opinion or predictions made, the Company represents
only that they were made in good faith.

 

    	6

    	 

    

 

(f)     All communications
by the Company with Placement Agent shall be with Placement Agent’s President, legal counsel and/or designated investment
banker(s) with respect to the Financing. The Company shall not communicate directly with any of Placement Agent’s brokers
or known clients (until such time as such clients are stockholders of the Company) without the prior consent of Placement Agent.
The provisions of this Section 6(f) shall not apply to clients of Placement Agent who are also stockholders of the Company.

 

7.     Indemnification.

 

(a)     The
Company agrees to indemnify and hold harmless Placement Agent, its officers, directors, employees, agents, legal counsel and any
of its affiliates (each, a “Placement Agent Indemnified Party”) against any and all losses, claims, damages,
liabilities, joint or several, and expenses (including all legal or other expenses reasonably incurred by a Placement Agent Indemnified
Party) caused by or arising out of any misrepresentation or untrue statement or alleged misrepresentation or untrue statement
of a material fact contained in the Memorandum or any other document furnished by the Company to Placement Agent for delivery
to or review by the Qualified Investors, or the omission or the alleged omission to state in such documents furnished to the Qualified
Investors a material fact necessary in order to make the statements therein not misleading in light of the circumstances under
which they were made, to the extent such misstatements or omissions are made in reliance upon and in conformity with written information
furnished by the Company for use in the documents furnished to the Qualified Investors, including the
Memorandum (except to the extent such misrepresentations, untrue statements or omissions are based on information
provided to the Company by Placement Agent). The Company agrees to reimburse the Placement Agent Indemnified Party for any reasonable
expenses (including reasonable fees and expenses of counsel) incurred as a result of producing documents, presenting testimony
or evidence, or preparing to present testimony or evidence (based upon time expended by the Placement Agent Indemnified Party
at its then current time charges or if such person shall have no established time charges, then based upon reasonable charges),
in connection with any court or administrative proceeding (including any investigation which may be preliminary thereto) arising
out of or relating to the performance by the Placement Agent Indemnified Party of any obligation hereunder and relating to a matter
for which the Company must provide indemnity to or hold harmless such Placement Agent Indemnified Party pursuant to the provisions
of this subsection (a). In the event the Company shall be obligated to indemnify a Placement Agent Indemnified Party in
connection with any such proceeding, the Company shall be entitled to assume the defense of such proceeding, with counsel approved
by the Placement Agent Indemnified Party (which shall not be unreasonably withheld), upon the delivery to the Placement Agent
Indemnified Party of written notice of the Company’s election to do so.

 

(b)     The Company
agrees to indemnify and hold harmless each Placement Agent Indemnified Party against any and all losses, claims, damages, liabilities,
joint or several, and expenses (including all legal or other expenses reasonably incurred by a Placement Agent Indemnified Party)
caused by or arising out of any breach by the Company of any financial or other arrangement, including, but not limited to, any
placement agent agreement, underwriting agreement or any other similar agreement or arrangement as of the date set forth above.

 

    	7

    	 

    

 

(c)     Placement
Agent agrees to indemnify and hold harmless the Company, its officers, directors, employees, agents, legal counsel and its affiliates
(each, a “Company Indemnified Party”) against any and all losses, claims, damages and liabilities, joint or
several, and expenses (including all legal or other expenses reasonably incurred by a Company Indemnified Party) caused by or
arising out of any misrepresentation or untrue statement or alleged misrepresentation or untrue statement of a material fact made
by Placement Agent to the Qualified Investors, or Placement Agent’s omission or the alleged omission to state to the Qualified
Investors a material fact necessary in order to make statements made not misleading in light of the circumstances under which
they were made (except to the extent such misrepresentations, untrue statements or omissions are based on information provided
to Placement Agent by the Company, including the Memorandum or any other document furnished by the Company to Placement Agent
for delivery to or review by the Qualified Investors). Placement Agent agrees to reimburse the Company Indemnified Party for any
reasonable expenses (including reasonable fees and expenses of counsel) incurred as a result of producing documents, presenting
testimony or evidence, or preparing to present testimony or evidence (based upon time expended by the Company Indemnified Party
at its then current time charges or if such person shall have no established time charges, then based upon reasonable charges),
in connection with any court or administrative proceeding (including any investigation which may be preliminary thereto) arising
out of or relating to the performance by the Company Indemnified Party of any obligation hereunder and relating to a matter for
which the Company must provide indemnity to or hold harmless such Placement Agent Indemnified Party pursuant to the provisions
of this subsection (b). Placement Agent’s obligations under this Section 7(b) shall be limited to the net
amount of Fees and expenses paid or payable by the Company to Placement Agent, other than fraud, intentional misrepresentation
or willful breach. In the event Placement Agent shall be obligated to indemnify a Company Indemnified Party in connection with
any such proceeding, Placement Agent shall be entitled to assume the defense of such proceeding, with counsel approved by the
Company Indemnified Party (which shall not be unreasonably withheld), upon the delivery to the Company Indemnified Party of written
notice of Placement Agent’s election to do so.

 

(d)     Notwithstanding
anything contained herein to the contrary, this Section 7 will survive expiration or termination of this Agreement
indefinitely.

 

    	8

    	 

    

 

8.     Confidentiality.
Except in keeping with its obligations under this Agreement, Placement Agent will maintain in confidence and will not use for its
own benefit any inventions, confidential know-how, trade secrets, financial information and other non-public information and data
disclosed to it by the Company, and it will not divulge the same to any other persons until such time as the information becomes
a matter of public knowledge. Placement Agent will use its best efforts to prevent any unauthorized disclosure described above
by others. This Section 8 will survive expiration or termination of this Agreement indefinitely.

 

9.     Expenses. The Company
shall pay Placement Agent a non-accountable expense fee equal to 3% of the gross proceeds received by the Company in the Financing.
This fee will be payable at each closing. The Company shall be responsible for all federal, state “blue sky” and other
filings pertaining to the Financing, including payment of such fees. Except as described above, each party shall bear its own fees
and expenses incurred in connection with the Financing. In addition, the Company shall also pay up to $25,000 for accountable expenses
that Placement Agent submits to the Company.

 

10.     Independent
Contractor. Placement Agent will perform its services hereunder as an independent contractor, and nothing in this Agreement
will in any way be construed to constitute Placement Agent the agent, employee or representative of the Company. Neither Placement
Agent nor any agent acting on behalf of Placement Agent will enter into any agreement or incur any obligations on the Company’s
behalf or commit the Company in any manner or make any representations, warranties or promises on the Company’s behalf or
hold itself (or allow itself to be held) as having any authority whatsoever to bind the Company without the Company’s prior
written consent, or attempt to do any of the foregoing.

 

11.     Subsequent Offerings.
The Company agrees that during the Term, Placement Agent shall serve as Company’s exclusive placement agent and that in the
event that the Company does an offering of its equity or debt securities subsequent to the Offering (“Subsequent Offering”)
during the Term, the Company will not approach any other person about acting as placement agent (or similar capacity) in connection
with such Subsequent Offering unless and until Placement Agent rejects the Company’s offer with respect to such Subsequent
Offering in writing. The terms of Placement Agent’s engagement with respect to any Subsequent Offering will be subject to
future negotiation by the Company and Placement Agent.

 

12.     General.

 

(a)     Reimbursement.
If any future financial dispute, discrepancy or controversy arises between or among the Company, its stockholders and/or Placement
Agent and results in Placement Agent causing an audit or accounting of the Company’s books and records, the Company shall
reimburse Placement Agent for the reasonable and documented expenses relating to such audit or accounting.

 

    	9

    	 

    

 

(b)     Arbitration.
The parties hereto agree that any dispute or controversy arising out of, relating to or concerning any interpretation, construction,
performance or breach of this Agreement, shall be subject to the laws of the State of Delaware without giving effect to its conflicts
of laws provisions. Any disputes will be settled in binding arbitration in Portland, Oregon under the auspices of FINRA dispute
resolution. The Arbitrator may grant injunctions or other relief in such dispute or controversy. The decision of the arbitrator
will be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision
in any court having jurisdiction. The parties shall each pay one-half of the costs and expenses of such arbitration, and each shall
separately pay its counsel fees and expenses.

 

(c)     Covenant
against Assignment. This Agreement is personal to the parties hereto, and accordingly, except for the right to enforce the
obligations under Sections 7 and 8 hereunder (which right shall inure to the benefit of the successors and assigns
of the aggrieved party), neither this Agreement nor any right hereunder or interest herein may be assigned or transferred or charged
by either party without the express written consent of the other.

 

(d)     Entire Agreement;
Amendment. This Agreement and the attached exhibits constitute the entire contract between the parties with respect to the
subject matter hereof and supersede any prior agreements between the parties. This Agreement may not be amended, nor may any obligation
hereunder be waived, except by an agreement in writing executed by, in the case of an amendment, each of the parties hereto, and,
in the case of a waiver, by the party waiving performance.

 

(e)     No Waiver.
The failure or delay by a party to enforce any provision of this Agreement will not in any way be construed as a waiver of any
such provision or prevent that party from thereafter enforcing any other provision of this Agreement. The rights granted both parties
hereunder are cumulative and will not constitute a waiver of either party’s right to assert any other legal remedy available
to it.

 

(f)     Severability.
Should any provision of this Agreement be found to be illegal or unenforceable, the other provisions will nevertheless remain effective
and will remain enforceable to the greatest extent permitted by law.

 

(g)     Notices.
Any notice, demand, offer, request or other communication required or permitted to be given by either the Company or Placement
Agent pursuant to the terms of this Agreement must be in writing and will be deemed effectively given the earlier of (i) when
received, (ii) when delivered personally, (iii) one business day after being delivered by facsimile (with receipt of
appropriate confirmation) to the number provided to the other party or such other number as a party may request by notifying the
other in writing, (iv) one business day after being deposited with an overnight courier service or (v) four days after
being deposited in the U.S. mail, First Class with postage prepaid, and addressed to the party at the address previously provided
to the other party or such other address as a party may request by notifying the other in writing.

 

    	10

    	 

    

 

(h)     Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which together
will constitute one and the same agreement. Facsimile copies of signed signature pages will be deemed binding originals.

 

[Signature Page Follows]

 

    	11

    	 

    

 

The parties have executed
this Placement Agent Agreement as of the date first written above.

 

	 	ANTRIABIO, INC.
	 	 
	 	By: 	/s/ Nevan Elam
	 	Name:	Nevan Elam
	 	Title: 	CEO
	 	 
	 	PAULSON INVESTMENT COMPANY, INC.
	 	 
	 	By: 	/s/ Tom Parigian
	 	Name:	Tom Parigian
	 	Title: 	Managing Partner

 

Signature
Page To Placement Agent Agreement

 

    	 

    	 

    

 

EXHIBIT A

 

Term Sheet 

 

    	13

    	 

    

 

EXHIBIT B

 

Individuals and Entities Who Are Not
Qualified Investors

 

    	14

    	 

    

 

EXHIBIT C

 

Investor Questionnaire

 

    	15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00226-of-00352.parquet"}]]